Authors :
Sahaya Asirvatham; Ekta Thakor
Volume/Issue :
Volume 6 - 2021, Issue 7 - July
Google Scholar :
http://bitly.ws/9nMw
Scribd :
https://bit.ly/3hYaYp2
Abstract :
The novel Coronavirus Disease (COVID-19)
also known as Severe Acute Respiratory Syndrome
coronavirus 2 (SARS-CoV-2) has transpired as a new
pandemic, threatening the world. The finding of a new
drug or vaccine would considerably take a long duration
of time. Hence the possible drug therapy includes repurposed already existing drugs against different
ailments. There are no guaranteed solutions to ensure
the spread of infectious diseases, before they reach
densely populated areas. But we need to have costeffective ways of widening the scope of its cure. This
review highlights the various re-modified uses of the
already existing xenobiotic for therapy of COVID-19 and
explains their plausible mechanism on the new virus.
Keywords :
Coronavirus Disease 2019, Severe Acute Respiratory Syndrome Coronavirus 2, World Health Organization.
The novel Coronavirus Disease (COVID-19)
also known as Severe Acute Respiratory Syndrome
coronavirus 2 (SARS-CoV-2) has transpired as a new
pandemic, threatening the world. The finding of a new
drug or vaccine would considerably take a long duration
of time. Hence the possible drug therapy includes repurposed already existing drugs against different
ailments. There are no guaranteed solutions to ensure
the spread of infectious diseases, before they reach
densely populated areas. But we need to have costeffective ways of widening the scope of its cure. This
review highlights the various re-modified uses of the
already existing xenobiotic for therapy of COVID-19 and
explains their plausible mechanism on the new virus.
Keywords :
Coronavirus Disease 2019, Severe Acute Respiratory Syndrome Coronavirus 2, World Health Organization.
